Owen Callaghan

1.3k total citations
33 papers, 827 citations indexed

About

Owen Callaghan is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Owen Callaghan has authored 33 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Owen Callaghan's work include Amino Acid Enzymes and Metabolism (3 papers), Allergic Rhinitis and Sensitization (3 papers) and Enzyme function and inhibition (3 papers). Owen Callaghan is often cited by papers focused on Amino Acid Enzymes and Metabolism (3 papers), Allergic Rhinitis and Sensitization (3 papers) and Enzyme function and inhibition (3 papers). Owen Callaghan collaborates with scholars based in United States, United Kingdom and Egypt. Owen Callaghan's co-authors include John A. Murphy, Rachel McMenamin, Miles Congreve, Gianni Chessari, Martyn Frederickson, Sahil Patel, Abraham Goldfarb, Christopher W. Murray, Alan R. Kennedy and Christopher Lampard and has published in prestigious journals such as Nature, The Journal of Immunology and Chemical Communications.

In The Last Decade

Owen Callaghan

32 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Owen Callaghan United States 15 385 241 226 90 85 33 827
Hans Hilpert Switzerland 18 426 1.1× 356 1.5× 112 0.5× 179 2.0× 157 1.8× 36 1.1k
Peter Hunt United Kingdom 18 519 1.3× 220 0.9× 273 1.2× 227 2.5× 157 1.8× 42 1.0k
Lise‐Lotte Olsson Sweden 12 395 1.0× 188 0.8× 251 1.1× 209 2.3× 141 1.7× 14 814
John J. Piwinski United States 21 538 1.4× 565 2.3× 83 0.4× 54 0.6× 122 1.4× 49 1.1k
Corinne Kay United Kingdom 11 452 1.2× 303 1.3× 191 0.8× 55 0.6× 160 1.9× 14 796
Brian A. McKittrick United States 16 306 0.8× 396 1.6× 105 0.5× 54 0.6× 101 1.2× 43 714
Mark J. Bamford United Kingdom 20 694 1.8× 524 2.2× 51 0.2× 56 0.6× 76 0.9× 41 1.2k
Robert Aslanian United States 23 623 1.6× 756 3.1× 79 0.3× 104 1.2× 109 1.3× 83 1.4k
Vı́ctor Segarra Spain 16 385 1.0× 500 2.1× 83 0.4× 40 0.4× 149 1.8× 41 899
Mingyun Shen China 14 687 1.8× 166 0.7× 299 1.3× 30 0.3× 90 1.1× 15 1.0k

Countries citing papers authored by Owen Callaghan

Since Specialization
Citations

This map shows the geographic impact of Owen Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Owen Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Owen Callaghan more than expected).

Fields of papers citing papers by Owen Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Owen Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Owen Callaghan. The network helps show where Owen Callaghan may publish in the future.

Co-authorship network of co-authors of Owen Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Owen Callaghan. A scholar is included among the top collaborators of Owen Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Owen Callaghan. Owen Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Esther R., William C. Dolowy, Louis Keith, et al.. (2015). Enhancement of Lymphosarcoma Transmission in Esox lucius and its Epidemiologic Relationship to Pollution1. Proceedings of the International Symposium on Comparative Leukemia Research. 245–251. 1 indexed citations
2.
Mosnaim, Aron D., Owen Callaghan, Thomas J. Hudzik, & Marion E. Wolf. (2013). Rat Brain-Uptake Index for Phenylethylamine and Various Monomethylated Derivatives. Neurochemical Research. 38(4). 842–846. 19 indexed citations
3.
Mosnaim, Aron D., et al.. (2013). Changes in Plasma Methionine-Enkephalin Levels Associated With a Cluster Headache Episode. American Journal of Therapeutics. 20(5). 463–468. 2 indexed citations
4.
Callaghan, Owen, Christopher Lampard, Alan R. Kennedy, & John A. Murphy. (1999). A novel route to (±)-aspidospermidine: First application of “radical-polar crossover” reactions to total synthesis. Tetrahedron Letters. 40(1). 161–164. 34 indexed citations
5.
Patro, Balaram, et al.. (1999). Tandem Radical Cyclizations on Iodoaryl Azides:  Synthesis of the Core Tetracycle of Aspidosperma Alkaloids. The Journal of Organic Chemistry. 64(21). 7856–7862. 30 indexed citations
6.
Callaghan, Owen & Xavier Franck. (1997). Unprecedented electrophilic behaviour of tetrathiafulvalenium salts. Chemical Communications. 1923–1923. 7 indexed citations
7.
Mosnaim, Aron D., Owen Callaghan, & Marion E. Wolf. (1989). Hydroxylation of phenylethylamine by rat liver preparations. Inhibition studies. General Pharmacology The Vascular System. 20(4). 463–467. 3 indexed citations
8.
Mosnaim, Aron D., et al.. (1988). Studies of the in vitro human plasma degradation of methionine-enkephalin. General Pharmacology The Vascular System. 19(5). 729–733. 21 indexed citations
9.
Mosnaim, Aron D., Marion E. Wolf, J Chevesich, Owen Callaghan, & Seymour Diamond. (1985). Plasma Methionine Enkephalin Levels — A Biological Marker for Migraine?. Headache The Journal of Head and Face Pain. 25(5). 259–267. 22 indexed citations
10.
Mosnaim, Aron D., et al.. (1982). Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjects. Clinica Chimica Acta. 126(3). 237–242. 6 indexed citations
11.
Koch, E, et al.. (1979). Water pollution and diseases in fish (an epizootiologic survey).. PubMed. 2(3). 917–25. 8 indexed citations
12.
Ungar, Frieda & Owen Callaghan. (1977). Studies on membrane receptor sites for serotonin in the brain.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(2). 205–24. 4 indexed citations
13.
Ungar, Frieda, Owen Callaghan, Ramesh Arora, & Spyridon G.A. Alivisatos. (1976). Subsynaptosomal localization and biochemical characterization of serotonin binding sites in the brain.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(3). 409–24. 1 indexed citations
14.
Spitzer, Robert H., et al.. (1973). Properties of rabbit antiragweed and antihorseradish peroxidase homocytotropic antibodies. Journal of Allergy and Clinical Immunology. 52(2). 63–72.
15.
Alivisatos, Spyridon G.A., Frieda Ungar, Owen Callaghan, & Claude G. Biava. (1964). Effect of Indoles and Imidazoles, Including Serotonin and Histamine, on the Morphology and Oxidative Phosphorylation of Guinea Pig Liver Mitochondria. Nature. 201(4914). 47–49. 6 indexed citations
16.
Callaghan, Owen & Abraham Goldfarb. (1962). Isolation and properties of an allergen from dwar ragweed pollen.. PubMed. 89. 612–22. 13 indexed citations
17.
Callaghan, Owen & Abraham Goldfarb. (1962). Isolation and Properties of an Allergen from Dwarf Ragweed Pollen. The Journal of Immunology. 89(5). 612–622. 12 indexed citations
18.
Goldfarb, Abraham & Owen Callaghan. (1961). Fractionation of the Antigens from Dwarf Ragweed Pollen. The Journal of Immunology. 86(1). 83–90. 23 indexed citations
19.
Callaghan, Owen & Gregorio Weber. (1959). Kinetic studies on rabbit-muscle myokinase. Biochemical Journal. 73(3). 473–485. 47 indexed citations
20.
Callaghan, Owen. (1957). The purification and properties of rabbit-muscle myokinase. Biochemical Journal. 67(4). 651–657. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans Hilpert Breakdown of academic impact, for papers by Peter Hunt Breakdown of academic impact, for papers by Lise‐Lotte Olsson Breakdown of academic impact, for papers by John J. Piwinski Breakdown of academic impact, for papers by Corinne Kay Breakdown of academic impact, for papers by Brian A. McKittrick Breakdown of academic impact, for papers by Mark J. Bamford Breakdown of academic impact, for papers by Robert Aslanian Breakdown of academic impact, for papers by Vı́ctor Segarra Breakdown of academic impact, for papers by Mingyun Shen
Rankless by CCL
2026